Quarterly Results

  • Company Name :
Natco Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524816
  • NSE Symbol:
  • NATCOPHARM
  • P/E(TTM):
  • 8.55
  • ISIN Demat:
  • INE987B01026
  • Div & Yield%:
  • 0.68
  • EPS(TTM):
  • 103.31
  • Book Value(₹):
  • 409.46
  • Market Cap(₹Cr.):
  • 15,828.83
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 1,157.40 407.60 1,292.60
Excise Duty 0.00 0.00 0.00
Net Sales 1,157.40 407.60 1,292.60
Other Operating Income 0.00 0.00 0.00
Other Income 62.10 168.00 51.40
Total Income 1,219.50 575.60 1,344.00
Total Expenditure 596.20 378.20 501.90
PBIDT 623.30 197.40 842.10
Interest 8.80 3.40 3.00
PBDT 614.50 194.00 839.10
Depreciation 93.70 43.70 42.20
Tax 99.40 27.90 147.80
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -6.70 -2.50 -12.00
Reported Profit After Tax 428.10 124.90 661.10
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 428.10 124.90 661.10
EPS (Unit Curr.) 23.90 6.97 36.91
EPS (Adj) (Unit Curr.) 23.90 6.97 36.91
Calculated EPS (Unit Curr.) 23.92 6.98 36.93
Calculated EPS (Adj) (Unit Curr.) 23.92 6.98 36.93
Calculated EPS (Ann.) (Unit Curr.) 95.66 27.91 147.73
Calculated EPS (Adj) (Ann.) (Unit Curr.) 95.66 27.91 147.73
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 75.00 75.00
Equity 35.80 35.80 35.80
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 53.85 48.43 65.15
PBDTM(%) 53.09 47.60 64.92
PATM(%) 36.99 30.64 51.14